Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic acid and clofibrate in the rat

Environmental Toxicology and Pharmacology

Volumn 2, Issue 4, 1996, Pages 351-357

  Bocos, Carlos ^a   Herrera, Emilio ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Cholesterol; Clofibrate; Etofibrate; Hypolipidemic drug; Lipolysis; Nicotinic acid; Rat; Triglyceride

Indexed keywords

ADRENALIN; CLOFIBRATE; ETOFIBRATE; FATTY ACID; GLYCEROL; NICOTINIC ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EPIDIDYMIS FAT; IN VITRO STUDY; LIPID ANALYSIS; LIPOLYSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030595999     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(96)00069-5     Document Type: Article

References (32)

1. Adult Treatment Panel II, 1993, Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults, J. Am. Med. Assoc. 269, 3015.
2. Bocos, C., M. Castro, G. Quack and E. Herrera, 1993, Studies with etofibrate in the rat. Part II: A comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysis, Biochim. Biophys. Acta Lipids Lipid Metab. 1168, 340.
3. Bocos, C., E. Orozco, M. Castro, G. Quack and E. Herrera, 1995, Effect of etofibrate on bile production in the normolipidemic rat, Gen. Pharmacol. 26, 537.
4. Carlström, S. and S. Laurell, 1968, The effect of nicotinic acid on the diurnal variation of the free fatty acids of plasma, Acta Med. Scand. 184, 121.
5. 14C]palmitate in the rat, Arch. Int. Physiol. Biochim. 88, 255.
6. Cayen, M.N., W.T. Robinson, J. Dubuc and D. Dvornik, 1979, Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats, Biochem. Pharmacol. 28, 1163.
7. D'Costa, M.A., W. Asico and A. Angel, 1979, Inhibition of rat and human adipocyte adenylate cyclase in the antilipolytic action of insulin, clofibrate, and nicotinic acid, Can. J. Biochem. 57, 1058.
8. Domínguez, M.C. and E. Herrera, 1976, The effect of glucose, insulin and adrenaline on glycerol metabolism in vitro in rat adipose tissue, Biochem. J. 158, 183.
9. Edens, N.K., R.L. Leibel and J. Hirsch, 1990, Mechanism of free fatty acid re-esterification in human adipocytes in vitro, J. Lipid Res. 31, 1423.
10. Fabiani, E., M. Crestani, B. Malavasi, M.D. Puppo, F. Farina, C. Armocida, S. Bellentani, G. Quack and E. Bosisio, 1989, The effect of etofibrate on cholesterol and bile acid metabolism in the hamster, Pharmacol. Res. 21, 567.
11. Fattore, P.C. and C.R. Sirtori, 1991, Nicotinic acid and derivatives, Curr. Opin. Lipidol. 2, 43.
12. Fears, R. 1987, Mode of action of lipid-lowering drugs, Baillieres Clin. Endocrinol. Metab. 1, 727.
13. Fuccella, L.M., G. Goldaniga, P. Lovisolo, E. Maggi, L. Musatti, V. Mandelli and C.R. Sirtori, 1980, Inhibition of lipolysis by nicotinic acid and by acipimox, Clin. Pharmacol. Ther. 28, 790.
14. Garland, P.B. and P.J. Randle, 1962, A rapid enzymatic assay for glycerol, Nature 196, 987.
15. Gaw, A. and J. Shepherd, 1991, Fibric acid derivatives, Curr. Opin. Lipidol. 2, 39.
16. Grahn, M.F. and J.I. Davies, 1980, Lipolytic agents as regulators of fatty acid esterification in rat adipose tissue [proceedings], Biochem. Soc. Trans. 8, 362.
17. Hammond, V.A. and D.G. Johnston, 1985, Measurement of substrate cycling in human adipocytes: a comparison of non-isotopic and isotopic techniques, Clin. Sci. 69 (suppl. 12), 15.
18. Hammond, V.A. and D.G. Johnston, 1987, Substrate cycling between triglyceride and fatty acid in human adipocytes, Metabolism 36, 308.
19. Hawkins, J.M., W.E. Jones, F.W. Bonner and G.G. Gibson, 1987, The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney, Drug Metab. Rev. 18, 441.
20. Hendricks, R. and K.G. Jensen, 1986, Comparison of the lipid-lowering action of bezafibrate retard and etofibrate retard in patients with type IIb hyperlipoproteinaemia, in: Pharmacological Control of Hyperlipidaemia, ed. R. Fears (J.R. Prous, Barcelona) p. 309.
21. Herrera, E., M.A. Lasunción, M. Castro, D. Gomez Coronado, A. Martín and G. Quack, 1988, Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism, Biochim. Biophys. Acta 963, 42.
22. Mampel, T., R. Camprodon, J. Solsona, V. Junca and E. Herrera, 1981, Changes in circulating glycerol, free fatty acids and glucose levels following liver transplant in the pig, Arch. Int. Physiol. Biochim. 89, 195.
23. Mampel, T., F. Villarroya and E. Herrera, 1985, Hepatectomy-nephrectomy effects in the pregnant rat and fetus, Biochem. Biophys. Res. Commun. 131, 1219.
24. Olsson, A.G., G. Walldius and G. Wahlberg, 1986, Nicotinic acid and its analogues. Mechanism of action, effects and clinical usage, in: Pharmacological Control of Hyperlipidaemia, ed. R. Fears (J.R. Prous, Barcelona) p. 217.
25. Palacín, M., M.A. Lasunción and E. Herrera, 1988, Utilization of glucose, alanine, lactate, and glycerol as lipogenic substrates by periuterine adipose tissue in situ in fed and starved rats, J. Lipid Res. 29, 26.
26. Probstfield, J.L. and D.B. Hunninghake, 1994, Nicotinic acid as a lipoprotein-altering agent: Therapy directed by the primary physician, Arch. Intern. Med. 154, 1557.
27. Robinson, J. and E.A. Newsholme, 1967, Glycerol kinase activities in rat heart and adipose tissue, Biochem. J. 104, 2c.
28. Rosenhamer, G. and L.A. Carlson, 1980, Effect of combined clofibrate-nicotinic acid treatment in ischemic heart disease, Atherosclerosis 37. 129.
29. Series, J.J., M.J. Caslake, C. Kilday, A. Cruickshank, T. Demant, C.J. Packard and J. Shepherd, 1988, Influence of etofibrate on low density lipoprotein metabolism, Atherosclerosis 69, 233.
30. Somogyi, M. 1945, Determination of blood sugar, J. Biol. Chem. 160, 69.
31. Stratton, G.D., D.D. Myles, P. Strong and I.F. Skidmore, 1985, The development of tolerance to antilipolytic agents by isolated rat adipocytes, Biochem. Pharmacol. 34, 275.
32. Tikkanen, M.J., T.S. Bocanegra, J. Findlay Walker, T. Cook and The Simvastatin Study Group, 1989, Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol, Am. J. Med. 87 (suppl.4A), 47S.